Yantai Dongcheng Biochemicals Co (SZSE:002675) Interest Expense : ¥-109 Mil (TTM As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Yantai Dongcheng Biochemicals Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Yantai Dongcheng Biochemicals Co's interest expense for the three months ended in Mar. 2025 was ¥ -28 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-109 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Yantai Dongcheng Biochemicals Co's Operating Income for the three months ended in Mar. 2025 was ¥ 80 Mil. Yantai Dongcheng Biochemicals Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -28 Mil. Yantai Dongcheng Biochemicals Co's Interest Coverage for the quarter that ended in Mar. 2025 was 2.90. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Yantai Dongcheng Biochemicals Co Interest Expense Historical Data

The historical data trend for Yantai Dongcheng Biochemicals Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yantai Dongcheng Biochemicals Co Interest Expense Chart

Yantai Dongcheng Biochemicals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-47.80

-56.45

-58.64

-44.32

-96.51

Yantai Dongcheng Biochemicals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-14.84	-7.09	-45.92	-28.66	-27.75

Yantai Dongcheng Biochemicals Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-109 Mil.

Yantai Dongcheng Biochemicals Co (SZSE:002675) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Yantai Dongcheng Biochemicals Co's Interest Expense for the three months ended in Mar. 2025 was ¥-28 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥80 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥439 Mil.

Yantai Dongcheng Biochemicals Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	80.494	/	-27.745
	=	2.90

The higher the ratio, the stronger the company's financial strength is.

Yantai Dongcheng Biochemicals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yantai Dongcheng Biochemicals Co Ltd (SZSE:002675) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 7 ChangBaishan Road, Yan Tai Development Zone, ShanDong, CHN, 264006

Website

http://www.dcb-group.com

Yantai Dongcheng Biochemicals Co Ltd is a biochemical analytical profile index (API) manufacturers in China. In addition, the company also focuses on the development of finished preparation which covers the therapeutic area of cardiovascular, oncology, orthopedics, and anti-infection. Its product offering includes heparin sodium, chondroitin sulfate, marine collagen, hyaluronic acid, glucosamine, heparinoids, and cytochrome C. The company's API products have been exported to more than fifty countries and regions, including the United States of America, Germany, Austria, and Japan.

Executives

Xin Hong Bo	Directors, executives
Luo Zhi Gang	Executives
You Shou Yi	Directors, executives
Lv Chun Xiang	Supervisors
Sun Hong Tao	Supervisors
Yi Qiong	Executives
Yang Zhen Qiu	Executives
Bai Xing Hua	Directors, executives
Song Zhao Long	Supervisors
Wen Lei	Director
Zhu Chun Ping	Executives
Qi Dong Qi	Directors, executives
Liu Xiao Jie	Securities Affairs Representative
Wang En Zheng	Independent director
Shi Tao	Supervisors

Yantai Dongcheng Biochemicals Co Headlines

No Headlines